Merck KGaA acquires Germany-based mRNA contract manufacturer
25.01.2021
MOSCOW (MRC) -- Merck KGaA says it has acquired AmpTec (Hamburg, Germany), a messenger RNA (mRNA) contract development and manufacturing organization (CDMO), according to Chemweek. The deal strengthens Merck's capabilities to develop and manufacture mRNA for its customers, for use in vaccines, treatments, and diagnostics applicable in COVID-19 and many other diseases, the company says. Fi